Opinions & Features

In his latest Forbes review, Dr. Steve Brozak examines The Code as Witness by Dr. Steven Quay and the broader questions it raises about scientific accountability, public trust, biotechnology, and future pandemic preparedness.

WBB Securities President Dr. Steve Brozak examines the growing concerns surrounding the 2026 Ebola outbreak, including institutional distrust, attacks on healthcare infrastructure, delayed containment efforts, and the broader implications for global public health preparedness.

WBB Securities President Dr. Steve Brozak examines five urgent questions emerging from the WHO’s emergency Hantavirus meeting, including transmission risks, global preparedness, and the broader implications for public health systems in a post-pandemic environment.

In a recent Forbes article, Dr. Steve Brozak examines HHS Secretary Robert F. Kennedy Jr.'s focus on the mental health crisis and the growing concern around psychiatric overprescribing. 

New insight from WBB Securities President Dr. Steve Brozak in Forbes. In “The U.S. 2026 Healthcare Cliff: When the Business Model Is the Real Risk,” Steve explores how the potential expiration of enhanced ACA subsidies could[...]

In his latest Forbes article, WBB Securities President Dr. Steve Brozak examines the hidden dangers behind recent Medicaid funding cuts buried within a sweeping federal spending bill. Titled "Diagnosing Medicaid Cuts To Hospitals In The[...]

Dr. Steve Brozak, President of WBB Securities, has authored a new opinion piece in Forbes

WBB Securities is pleased to share a featured interview with our Managing Director, Dr. Steve Brozak, published in The Wall Street Transcript on April 29, 2025.

Pharmaceutical tariffs are looming again, and the stakes are higher than ever.